Replies to post #766631 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

I have mentioned this before. The percentage of the dilution is always greatly exaggerated by the percentage in pps drop, by a large multiple. The only correlation is the direction.

]
Is that true on a long term basis?

By this time 9 years ago the stock had slid to about $2 on FDA hold, the blowup between with their only serious funder and the likely long road ahead to counter whatever happened in 2015. Since then the dilution has been 10 fold so the PPS has matched that.

One can of course chose time ranges either way to make it look different. But to just assert the effect is exagerated is an opinion is all.

And please don't bother with all the spin on how much better things are now. Back then the trial could have been a success as designed. It could have show a legit OS w/o resorting to comps created by counting ticks on a publish K/M chart (including ones certain longs here mock as being faked).

[jesster64]

"You don’t want to pump up an unapproved product or be accused of trying to influence any MHRA decision making, so quiet is safe!"

Quiet has gotten us to .25 a share.
This is the same cut and paste answer that is given every time someone says the company should be more vocal in what they are doing and have accomplished. Its always "you cant talk about an ongoing lawsuit and you dont want to piss off the MHRA"
I have given a few examples of things they can promote, patents, long tail survivor anniversaries, etc ..; however, that is not my job. They are lawyers, I am sure they can figure out some things that would interest potential stockholders.
So there IS a correlation between dilution and lower SP.
Imagine what would have happened if there was a PR after the 24% SP rise. Would that have kept the momentum up? We'll never know.
JMO